Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia
Clinical trial NCT03932877 · COMPLETED
Trial details
- NCT number
- NCT03932877
- Sponsor
- Cengiz Gokcek Women's and Children's Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-30
- Primary completion
- 2018-11-30
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.